2019 Sales of 5 Large Pharmaceutical Companies With Cardiovascular Portfolio:
1. Bristol-Myers Squibb: $7.9 Bil (40%)
2. Pfizer: $5.7 Bil (28%)
3. AstraZeneca: $4.1 Bil (17%)
4. Johnson & Johnson: $3.0 Bil (15%)
5. Novartis: $1.7 Bil (9%)
6. Merck: $1.7 Bil (8%)
--------------------------------------------------------------
Total Cardiovascular Sales: $24.2 Bil
What Has Changed?
From 2015 To 2019
Bristol-Myers Squibb: $6.0 Bil
+ Novartis: $1.7 Bil
+ Pfizer: $(0.1) Bil
+ Johnson & Johnson: $(0.1) Bil
+ Merck: $(2.1) Bil
+ AstraZeneca: $(2.9) Bil
-----------------------------------------------------------
Total Change 2015-2019: $2.6 Bil
+ Total Sales In 2015: $21.6 Bil
= Total Sales In 2019: $24.2 Bil*
*figures may not add up due to rounding.